Discover the latest advancements in osteoporosis treatment for postmenopausal women. New medications, including Romosozumab and Denosumab, offer hope and convenience, promising better bone health and ...

Bone is always being absorbed and remanufactured, but in osteoporosis bone is broken down quicker than it is replaced. Alendronic acid belongs to a group of drugs called bisphosphonates ...

Nonadherence to pharmacological treatment in osteoporosis is a well-recognized problem. As in other chronic diseases, adherence to osteoporosis treatment is poor, resulting in enormous burden on ...

Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from ...

Another problem is the issue of fertility and reproduction. Osteoporosis requires long-term use of drugs that have not been tested on pregnant women, and their influence on fetus growth and ...

Researchers have identified that the protein CLEC14A disrupts the maturation of bone cells, delaying bone formation. The ...

Scientists at the University of Rochester are delving into one of the long-standing questions in medical science: why and how ...

In this Avera Medical Minute, one woman shares how she is taking care of her bone health after being diagnosed with ...

If you’re at an increased risk for osteoporosis—a condition affecting one in three women over 50—you know how important it is ...

Unfortunately, osteoporosis cannot be fully reversed, but you can still prevent further bone loss. “Once you’ve lost that bone density, you’re not going to get it back to the way it was ...

Most conventional anti-osteoporosis medications are contraindicated in CKD patients because they may worsen renal function. Therefore, there was urgent need to develop safe and effective drugs for ...

A significant decrease in the prevalence of osteoporosis and associated fractures among patients ... with early osteological assessment and the use of biological disease-modifying antirheumatic drugs ...